Ascentage Pharma Group International (OTCMKTS:ASPHF – Get Free Report) is expected to release its results before the market opens on Wednesday, August 19th. Analysts expect the company to post earnings of ($0.0552) per share and revenue of $53.8480 million for the quarter.
Ascentage Pharma Group International Stock Performance
OTCMKTS:ASPHF opened at $4.53 on Wednesday. Ascentage Pharma Group International has a 12 month low of $4.53 and a 12 month high of $5.05. The stock has a 50 day moving average of $4.54 and a two-hundred day moving average of $6.78.
About Ascentage Pharma Group International
Ascentage Pharma Group International (OTCMKTS:ASPHF) is a clinical-stage biopharmaceutical company headquartered in Beijing, China, with a strategic presence in the United States. The company focuses on the discovery and development of targeted small-molecule therapies that modulate programmed cell death, leveraging a deep understanding of the Bcl-2 family of proteins.
Ascentage’s core activities center on the research and development of apoptosis regulators, including both Bcl-2 selective and dual Bcl-2/Bcl-xL inhibitors.
Read More
- Five stocks we like better than Ascentage Pharma Group International
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
